Canvas Dx: AI Powered App To Diagnose Autism Gets FDA Marketing Authorization

Canvas Dx: AI Powered App To Diagnose Autism Gets FDA Marketing Authorization

The app asks moms and dads to answer a questionnaire related to their kids habits patterns and also upload videos of their kid in their natural surroundings. When submitted, the reactions and videos are sent to a skilled expert who observes the reactions and videos and provides their own input. The childs pediatrician likewise supplies their reactions about the childs behavior.

Head to the post from last year to learn more about this app. You can likewise register to get updates on Canvas Dx.

The FDA approval comes after an evaluation done on 425 kids aged 18 months to 5 years throughout varied a group of clients in regards to race, gender, education, and socioeconomic status.

Back in October 2020, Cognoa, a company that makes diagnostic tools and digital therapeutics, sent an Artificial Intelligence powered tool for FDA approval that intends to help identify Autism in kids. Just recently, Cognoa received approval from FDA for its Canvas Dx software and will start to market this software application later this year.

Usually, the majority of kids are diagnosed around the age of four but the goal is to diagnose them much quicker– at the age of eighteen months, so they can have access to services like speech therapy as quickly as possible. The current system is unable to provide early diagnoses to lots of kids and families.

Source: PR Newswire, MedCityNews

Related